Systemic mastocytosis with subcutaneous hemorrhage and edema in a Greyhound dog: case report and review of diagnostic criteria.
Alexander AceinoUnity JefferyJulie PiccioneCarolyn L HodoPublished in: Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc (2020)
Systemic mastocytosis, characterized by infiltration of multiple organs by neoplastic mast cells, is a well-described entity in human medicine with specific criteria for diagnosis, but is ill defined in veterinary literature. Hemostatic disorders are reported in humans affected by systemic mastocytosis but have not been well described in veterinary literature. A 5-y-old, spayed female Greyhound dog had a 1-mo history of progressive ventral cutaneous edema, hemorrhage, and pain. Cytology of an antemortem aspirate from the subcutis of the ventral abdomen was suggestive of mast cell neoplasia, but no discrete mass was present. The dog was euthanized and submitted for autopsy; marked subcutaneous edema and hemorrhage were confirmed. The ventral abdominal panniculus and dermis superficial to the panniculus carnosus were infiltrated by a dense sheet of neoplastic mast cells. The neoplastic cells contained toluidine blue-positive granules and formed aggregates within the bone marrow and several visceral organs, including the liver, spleen, heart, and kidney. Diffuse edema and hemorrhage is an unusual presentation of mast cell tumors in dogs. Antemortem tests, including complete blood count, coagulation profile, and viscoelastic coagulation testing, were suggestive of a primary hemostatic defect. We discuss here the diagnostic criteria used in humans, how these can be applied to veterinary patients, and the limitations of the current diagnostic framework.
Keyphrases
- spinal cord
- bone marrow
- systematic review
- deep brain stimulation
- end stage renal disease
- high grade
- induced apoptosis
- prefrontal cortex
- ejection fraction
- newly diagnosed
- endothelial cells
- chronic pain
- neuropathic pain
- heart failure
- mesenchymal stem cells
- chronic kidney disease
- multiple sclerosis
- type diabetes
- prognostic factors
- pain management
- low grade
- insulin resistance
- atrial fibrillation
- atomic force microscopy
- cell cycle arrest
- metabolic syndrome
- drug induced
- spinal cord injury
- cell proliferation
- skeletal muscle
- patient reported
- ultrasound guided
- postoperative pain
- signaling pathway